SLC25A19 and metabolic dysfunction-associated steatotic liver disease: MUP1 and MUP2 have been previously regarded as the regulators of glucose and lipid metabolism [33,34,35,36], whereas in our study, as a newly identified downregulated protein in both the db/db mouse liver and serum, the role of MUP3 in NAFLD is unclear.